Insulet
PODD
#2029
Rank
S$11.91 B
Marketcap
S$171.79
Share price
-2.96%
Change (1 day)
-62.06%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): S$0.78 Billion

According to Insulet's latest financial reports the company's current earnings are S$3.18 Billion. In 2025 the company made an earning of S$0.51 Billion, an increase over its 2024 earnings that were of S$0.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.78 B51.85%
2025 S$0.51 B16.3%
2024 S$0.44 B36.76%
2023 S$0.32 B481.9%
2022 S$55.59 M-45.24%
2021 S$0.10 B43.35%
2020 S$70.82 M18.51%
2019 S$59.76 M41.16%
2018 S$42.33 M-711.95%
2017 -S$6.92 Million-56.85%
2016 -S$16.04 Million-79.31%
2015 -S$77.52 Million63.85%
2014 -S$47.31 Million31.04%
2013 -S$36.11 Million-21.96%
2012 -S$46.27 Million
2010 -S$44.13 Million-42.38%
2009 -S$76.58 Million-33.56%
2008 -S$0.12 Billion65.93%
2007 -S$69.46 Million209.75%
2006 -S$22.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.15 B 2,977.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$9.31 B 1,086.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$9.45 B 1,104.47%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$44.85 B 5,614.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-S$78.69 Million-110.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
S$0.10 B-86.38%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
S$1.64 B 109.70%๐Ÿ‡บ๐Ÿ‡ธ USA